This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will be not be issued.

This combined synopsis/solicitation issued as a Request for Quote (RFQ).

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has a requirement for the brand or name or equal Qiagen CLC Genomics Workbench software in accordance with (IAW) the Minimum Essential Characteristics (MECS) identified in the attached Request for Quote (RFQ).

The acquisition is full and open competition using the Lowest Price Technically Acceptable (LPTA) selection procedures. Reference attached RFQ for detailed information on the requirement, how to respond, and evaluation criteria.

The RFQ closes on Wednesday, 10 August 2016 at 10:00 A.M. EST.
This RFQ as well as any amendments will be used electronically in accordance with FAR 4.502 and FAR 5.102. As a result, hard copies will not be provided.

 

Bid Protests Not Available